Human Infection with Highly Pathogenic A(H7N7) Avian Influenza Virus, Italy, 2013 - Volume 20, Number 10—October 2014 - Emerging Infectious Disease journal - CDC
Volume 20, Number 10—October 2014
Human Infection with Highly Pathogenic A(H7N7) Avian Influenza Virus, Italy, 2013
In Europe, avian influenza viruses of subtype H7 have been responsible for several disease outbreaks among poultry, which resulted in human infections (1,2). Notably, since 2000, outbreaks of avian influenza caused by high and low pathogenicity influenza A(H7N1) viruses and low pathogenicity A(H7N3) viruses occurred on poultry farms located mainly in northeastern Italy (3). On August 14, 2013, infection caused by a highly pathogenic avian influenza A(H7N7) virus was initially detected on a layer farm in Ostellato, Ferrara Province, Italy, representing the start of an epizootic that affected another 5 poultry farms in Ferrara and Bologna Provinces (Emilia-Romagna Region) during the next 3 weeks. Nearly 1 million chickens on the 6 farms were culled (4). All workers (≈200) who participated in depopulating infected premises applied strict infection prevention procedures and were monitored for symptoms. Among the workers, infection with highly pathogenic A(H7N7) avian influenza virus was confirmed for 3 who had conjunctivitis but no respiratory symptoms. We describe the clinical and virologic findings of the investigation conducted with regard to these 3 human cases of influenza A(H7N7) virus infection.
Dr Puzelli is a researcher in the Department of Infectious, Parasitic and Immune-mediated Diseases at the National Institute of Health, Rome. Her primary research interests include molecular mechanisms of genetic variability of influenza viruses and antiviral susceptibility.
We are grateful to Ruth Manvell, Ian Brown, and Bob Newman for supplying antiserum for hemagglutination inhibition testing and to Tiziana Grisetti for editing the manuscript.
This work was funded by the Italian Ministry of Health project “Virological surveillance of epidemic and pandemic influenza” (grant no. 4M13) and by the Emilia-Romagna Region. Work at the Medical Research Council National Institute for Medical Research was funded by Medical Research Council program no. U117512723.
- Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004;363:587–93.
- Belser JA, Bridges CB, Katz JM, Tumpey TM. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis.2009;15:859–65.
- Campitelli L, Mogavero E, De Marco MA, Delogu M, Puzelli S, Frezza F, Interspecies transmission of an H7N3 influenza virus from wild birds to intensively reared domestic poultry in Italy. Virology. 2004;323:24–36.
- Bonfanti L, Monne I, Tamba M, Santucci U, Massi P, Patregnani T, Highly pathogenic H7N7 avian influenza in Italy. Vet Rec. 2014;174:382.
- Centers for Disease Control and Prevention. CDC human influenza virus real-time RT-PCR diagnostic panel–-influenza A/H7 (Eurasian Lineage) assay [cited 2014 Jun 20]. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM349065.pdf
- Monne I, Ormelli S, Salviato A, De Battisti C, Bettini F, Salomoni A, Development and validation of a one-step real-time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses. J Clin Microbiol. 2008;46:1769–73.
- Istituto Zooprofilattico Sperimentale delle Venezie. Highly pathogenic avian influenza subtype H7N7, Italy, August 2013. Laboratory and molecular findings [cited 2014 Jun 20].http://www.izsvenezie.it/images/stories/Pdf/Temi/Aviaria/situazione_epidemiologica2013/presentazione_def_09_2013.pdf
- World Health Organization. Manual for the laboratory diagnosis and virological surveillance of influenza [cited 2014 Apr 14].http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf?ua=1
- Wood GW, McCauley JW, Bashiruddin JB, Alexander DJ. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes. Arch Virol. 1993;130:209–17.
- Matsuoka Y, Swayne DE, Thomas C, Rameix-welti MA, Naffakh N, Warmes C, Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J Virol. 2009;83:4704–8.
- Aoki FY, Boivin G, Roberts N. Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther. 2007;12:603–16 .
- Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 2001;293:1840–2.
- Munster VJ, de Wit E, van Riel D, Beyer WE, Rimmelzwaan GF, Osterhaus AD, The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis. 2007;196:258–65.
- Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985;4:3021–4.
- de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T, Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol. 2010;84:1597–606.
Suggested citation for this article: Puzelli S, Rossini G, Facchini M, Vaccari G, Di Trani L, Di Martino A, et al. Human infection with highly pathogenic A(H7N7) avian influenza virus, Italy, 2013. Emerg Infect Dis [Internet]. 2014 Oct [date cited]. http://dx.doi.org/10.3201/eid2010.140512
1Influenza Task Force members: Laura Calzoletti, Concetta Fabiani, Monica Meola, Annapina Palmieri, Arianna Boni, Guendalina Zaccaria (Istituto Superiore di Sanità, Rome); Marisa Cova, Valerio Parmeggiani, Claudio Po, Roberto Cagarelli, Gabriele Squintani, Emanuela Bedeschi (Emilia-Romagna Region, Bologna); and Maria Grazia Pompa (Ministry of Health, Rome).